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Abstract. 
 
We have shown in a variety of human 
wounds that collagenase-1 (MMP-1), a matrix metallo-
proteinase that cleaves fibrillar type I collagen, is in-
variably expressed by basal keratinocytes migrating 
across the dermal matrix. Furthermore, we have dem-
onstrated that MMP-1 expression is induced in primary 
keratinocytes by contact with native type I collagen and 
not by basement membrane proteins or by other com-
ponents of the dermal or provisional (wound) matrix. 
Based on these observations, we hypothesized that the 
catalytic activity of MMP-1 is necessary for kerati-
nocyte migration on type I collagen. To test this idea, 
we assessed keratinocyte motility on type I collagen us-
ing colony dispersion and colloidal gold migration as-
says. In both assays, primary human keratinocytes mi-
grated efficiently on collagen. The specificity of MMP-1 
in promoting cell movement was demonstrated in four 
distinct experiments. One, keratinocyte migration was 
completely blocked by peptide hydroxymates, which 
are potent inhibitors of the catalytic activity of MMPs. 
Two, HaCaTs, a line of human keratinocytes that do 
not express MMP-1 in response to collagen, did not mi-
grate on a type I collagen matrix but moved efficiently 
on denatured type I collagen (gelatin). EGF, which in-
duces MMP-I production by HaCaT cells, resulted in 
the ability of these cells to migrate across a type I col-
lagen matrix. Three, keratinocytes did not migrate on 
mutant type I collagen lacking the collagenase cleavage 
site, even though this substrate induced MMP-1 expres-
sion. Four, cell migration on collagen was completely 
blocked by recombinant tissue inhibitor of metallopro-
teinase-1 (TIMP-1) and by affinity-purified anti–MMP-1 
antiserum. In addition, the collagen-mediated induc-
tion of collagenase-1 and migration of primary kerati-
nocytes on collagen was blocked by antibodies against 
the 
 
a
 
2 integrin subunit but not by antibodies against the 
 
a
 
1 or 
 
a
 
3 subunits. We propose that interaction of the 
 
a
 
2
 
b
 
1 integrin with dermal collagen mediates induction 
of collagenase-1 in keratinocytes at the onset of healing 
and that the activity of collagenase-1 is needed to ini-
tiate cell movement. Furthermore, we propose that 
cleavage of dermal collagen provides keratinocytes 
with a mechanism to maintain their directionality dur-
ing reepithelialization.
 
N
 
ormal
 
 cutaneous wound healing, as well as healing
in essentially all tissues, involves an orderly pro-
gression of events to reestablish the integrity of
the injured tissue. The initial injury starts a programmed
series of independent yet separate responses that includes
reepithelialization and epithelial proliferation, inflamma-
tion, angiogenesis, fibroplasia, matrix accumulation, and
eventually resolution. During each stage in this process,
proteinases are needed to remove or remodel extracellular
matrix components in both the epithelial and interstitial
compartments, thereby accommodating cell migration and
tissue repair (Mignatti et al., 1996).
Although extracellular matrix proteins can be degraded
by various proteinases, fibrillar type I collagen, the most
abundant protein in the dermis, is resistant to degradation
by most enzymes. Collagen degradation is initiated by the
catalytic activity of collagenases, a subgroup of the matrix
metalloproteinase (MMP)
 
1
 
 gene family, with the unique
ability to cleave fibrillar collagen types I, II, and III at a
specific locus in their triple-helical domain. At physiologi-
cal temperature, cleaved collagen molecules denature into
gelatin and become susceptible to further digestion by
other proteinases. Of the three known human metallocol-
lagenases, collagenase-1 (MMP-1) seems to be the enzyme
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tissue inhibi-
tor of metalloproteinases-1.
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that is principally responsible for collagen turnover in
most tissues. In a variety of normal and disease-associated
tissue remodeling events, collagenase-1 may be expressed
by epithelial cells, fibroblasts, endothelial cells, chondro-
cytes, and macrophages (Saarialho-Kere et al., 1992, 1993
 
a
 
;
Stricklin et al., 1993; Wolfe et al., 1993; Fisher et al., 1994;
Galis et al., 1994). Collagenase-2 (MMP-8) is found only in
neutrophils and chondrocytes (Hasty et al., 1990; Chubin-
skaya et al., 1996), and collagenase-3 (MMP-13), originally
cloned from a breast carcinoma line (Freije et al., 1994), is
also expressed in articular cartilage (Mitchell et al., 1996;
Reboul et al., 1996) and developing bone (Gack et al.,
1995).
In a thorough examination of normally healing wounds
and a variety of chronic ulcers, we found that collagenase-1
is invariably expressed by basal keratinocytes at the lead-
ing edge of repairing tissue and that expression of this MMP
in the epidermis diminishes rapidly away from the wound
margin (Saarialho-Kere et al., 1992, 1993
 
a
 
). In a time-course
study of reepithelialization in human skin, Inoue et al.
(1995) reported that collagenase-1 expression is detectable
as early as 4 h after wounding, when migration is first ap-
parent, and shuts off upon reformation of a contiguous
epidermis. In chronic ulcers, collagenase-1 is expressed at
higher levels and over a greater length of epidermis com-
pared to that seen in acute wounds (Saarialho-Kere et al.,
1993
 
a
 
), suggesting that overexpression of this MMP may
contribute to the inability of certain lesions to heal. Impor-
tantly, this enzyme is always expressed by migrating kera-
tinocytes that have moved off of an intact basement mem-
brane and are in contact with dermal and provisional
matrices (Saarialho-Kere et al., 1993
 
a
 
). Conversely, wound
epidermal cells on an intact basement membrane, such as
seen in certain forms of blisters (Saarialho-Kere et al., 1995),
and on nonwounded epidermis do not express this MMP.
Our in vivo findings suggest that altered cell–matrix in-
teractions influence collagenase-1 expression during reepi-
thelialization. Indeed, we have shown that native type I
collagen selectively supports primary human keratinocyte
attachment and induces collagenase-1, whereas denatured
collagen (gelatin), purified or combined basement mem-
brane proteins, or other dermal-wound bed matrix compo-
nents do not (Saarialho-Kere et al., 1993
 
a
 
; Sudbeck et al.,
1994). Furthermore, we showed that contact with native
type I collagen induces collagenase-1 transcription and is
blocked by tyrosine kinase antagonists (Sudbeck et al.,
1994). Thus, contact with dermal type I collagen is an im-
portant determinant in regulating the response of basal
keratinocytes to injury. Indeed, in this report, we show
that blocking antibodies to the 
 
a
 
2 subunit of the 
 
a
 
2
 
b
 
1 inte-
grin inhibits collagen-mediated induction of collagenase-1
in keratinocytes.
The invariable expression of collagenase-1 in all forms
of wounds and the confinement of its expression to peri-
ods of active reepithelialization suggests that this enzyme
plays a critical role in keratinocyte migration during wound
repair. Beyond directly remodeling structural proteins,
MMPs are thought to break down extracellular matrix
barriers that impede cell migration. Clearly, this is a rea-
sonable role for these proteinases in facilitating cell move-
ment through a three-dimensional matrix, as is seen during
blastocyst invasion (Librach et al., 1991), angiogenesis
(Fisher et al., 1994), and extravasation and infiltration of
inflammatory cells (Shipley et al., 1996). During normal
reepithelialization, however, keratinocytes migrate along
a path of least resistance, dissecting underneath the scab
while remaining superficial to the underlying dermis and
wound bed (Stenn and Malhotra, 1992). Thus, epidermal
repair involves cell migration in a two-dimensional plane
rather than through a three-dimensional matrix-rich envi-
ronment. As reported here, our findings indicate that ke-
ratinocytes use collagenase-1 to cleave collagen to gelatin,
thereby providing a substrate that is more conducive to
migration. Without collagenolytic activity, these cells do
not migrate on a collagen-containing matrix. We propose
that the ability of keratinocytes to bind tightly to collagen
and subsequently cleave the fibrils provides a mechanism
that maintains the directionality of reepithelialization.
 
Materials and Methods
 
Cell Culture
 
Primary keratinocytes were isolated from full thickness skin obtained
from reductive mammoplasty or lateral abdominoplasty and grown in
DME (1.8 mM Ca
 
2
 
1
 
) as described (Pentland and Needleman, 1986; Sud-
beck et al., 1994). Cells were plated on dishes or slides precoated with 1.0
mg/ml solution bovine type I monomeric collagen (Vitrogen; Collagen
Corp., Palo Alto, CA) or with 1.0 
 
m
 
g/ml gelatin made by heating type I
collagen at 80
 
8
 
C for 10 min. The HaCaT human keratinocyte cell line
(Boukamp et al., 1988) was provided by Dr. Norbert Fusenig (German
Cancer Research Center, Heidelberg, Germany) and was grown in DME
containing 10% heat-inactivated FCS, 1% Hepes, and antibiotics. Colla-
genase-1 accumulation in the medium was quantified by competitive
ELISA and normalized to total cellular protein (Sudbeck et al., 1994).
RNA isolation and detection of collagenase-1 mRNA by reverse tran-
scriptase–PCR were done as described in detail (Sudbeck et al., 1997). To-
tal protein synthesis was determined in cultured keratinocytes as de-
scribed (Sudbeck et al., 1994).
 
In Situ Hybridization
 
Collagenase-1 mRNA was detected in formalin-fixed tissue samples and cul-
tured cells by hybridization with 
 
35
 
S-labeled antisense RNA as described
(Prosser et al., 1989; Saarialho-Kere et al., 1993
 
b
 
). For in situ hybridiza-
tion of acute wounds, we obtained sections of intact and 2-d wounded
neonatal human foreskin grafted onto severe combined immunodefi-
ciency (SCID) mice from Drs. Horace DeLister and Steven Albelda (Uni-
versity of Pennsylvania, Philadelphia, PA). The creation of these grafted
mice and the incisional wounding and biopsy procedures have been de-
scribed in detail (Juhasz et al., 1993). Keratinocytes were grown on col-
lagen-coated Lab-Tek chamber slides (Nunc, Naperville, IL) and were hy-
bridized with 2.5 
 
3
 
 10
 
4
 
 cpm/
 
m
 
l of 
 
35
 
S-labeled antisense or sense RNA
overnight at 57
 
8
 
C. After hybridization, slides were washed under stringent
conditions, including RNase A treatment, and were processed for autora-
diography.
 
Colloidal Gold Migration Assay
 
Keratinocytes were plated on chamber slides precoated with a mixture of
100 
 
m
 
g/ml type I collagen or gelatin or no matrix and colloidal gold parti-
cles in serum-containing DME with or without 30 ng/ml EGF (R&D Sys-
tems Inc., Minneapolis, MN). Colloidal gold–coated chamber slides were
prepared as described (Albrecht-Buehler, 1977) with modifications for ke-
ratinocytes and the inclusion of matrix proteins (Woodley et al., 1988; Kim
et al., 1994). Primary or HaCaT keratinocytes (about 330 cells in 0.3 ml)
were added to each chamber, and 20 min later, nonadherent cells were re-
moved and the medium was replaced. 20 h after plating, cultures were
fixed in 1
 
3
 
 Histochoice tissue fixative (Amresco, Solon, OH) for 1 min,
washed in PBS, and dehydrated through graded ethanols. Paths of cell mi-
gration (phagokinetic tracks) were identified by areas devoid of gold par-
ticles. A migration index was determined using image analysis software by 
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measuring the area of phagokinetic tracks associated with cells in ran-
domly chosen fields under dark-field illumination at 100
 
3
 
. All cells in a
field were counted, and 20 cells were counted for each chamber. For each
experiment, all conditions were done in duplicate, and all experiments
were repeated at least four times with keratinocytes from different do-
nors. The migration index of keratinocytes on colloidal gold with no ma-
trix was essentially zero and was subtracted from experimental points.
 
Colony Dispersion Migration Assay
 
Keratinocyte migration was also assessed in a colony dispersion assay by
plating 10
 
4
 
 cells suspended in 150 
 
m
 
l DME within a siliconized cloning cyl-
inder (6-mm internal diameter; Bellco Glass, Inc., Vineland, NJ) onto col-
lagen- or gelatin-coated dishes. After a 24-h incubation period to allow
the cells to attach and become confluent, the cylinder was removed, and
cell colonies were allowed to migrate for 0, 24, 48, 96, or 120 h at 37
 
8
 
C in a
5% CO
 
2
 
 humidified incubator. Keratinocytes were fixed and stained with
1.5% Coomassie blue, and the area of the colony was determined by digi-
tized scanning analysis. Migration is expressed as the increase in colony
area relative to 0-h controls.
Various reagents were added to promote or inhibit keratinocyte migra-
tion. In studies with HaCaT keratinocytes, collagenase-1 expression was
induced with 30 ng/ml EGF (R&D Systems, Inc.). HaCaT proliferation in
response to EGF was inhibited by treating cells with 100 mM hydroxyurea
(HU; Sigma Chemical Co., St. Louis, MO) 24 h before addition of EGF.
Peptide hydroxymate compounds SC44463 and SC44201 were used at
25 
 
m
 
M and were provided by Monsanto-Searle, Inc. (St. Louis, MO). Col-
lagenase-1 antibody was affinity-purified and characterized as described
(Saarialho-Kere et al., 1993
 
a
 
). This polyclonal antibody recognizes both
the zymogen and activated forms of collagenase-1, free or bound to TIMP-1,
and fully inhibits the catalytic activity of collagenase-1. In an in vitro deg-
radation assay, a 1:20 dilution of collagenase antibody completely inhib-
ited the cleavage of type I collagen monomers by 5 
 
m
 
g/ml of purified hu-
man collagenase-1 (data not shown). Ammonium sulfate–precipitated
nonimmune IgG (1:10 dilution) was used as a control in the antibody-
blocking experiments. Recombinant human TIMP-1 (50 
 
m
 
g/ml), which has
full MMP-inhibitory activity, was provided as a gift from Dr. David Car-
michael (Synergen Corporation, Boulder, CO). Wild-type and collage-
nase-1–resistant mouse type I collagens were used at 100 
 
m
 
g/ml. Genera-
tion of the mice and characterization of the mutant collagen were
reported earlier (Wu et al., 1990; Liu et al., 1995). Monoclonal blocking
antibodies to integrin subunits were purchased from Chemicon Interna-
tional Inc. (Temecula, CA) and were mAB1973 (anti-
 
a
 
1), mAB1950
(anti-
 
a
 
2), and mAB1952 (anti-
 
a
 
3). Integrin antibodies were added to a fi-
nal concentration of 10 
 
m
 
g/ml. To prevent blocking of cell adhesion, kera-
tinocytes were plated 2 h before addition of integrin-blocking antibodies.
 
Thiopeptolide Assay
 
Inhibition of MMP degradation of the thiopeptolide substrate Ac-Pro-
Leu-Gly-thioester-Leu-Leu-Gly-Oet (BACHEM Bioscience, King of Prus-
sia, PA) (Shipley et al., 1996) was used to determine the activity of
SC44463 in tissue culture. We obtained recombinant 92-kD gelatinase cat-
alytic domain, which is spontaneously active, from Dr. J. Michael Shipley
(Washington University, St. Louis, MO) and used this protein as a source
of MMP activity to generate an initial cleavage rate. The inhibitory activ-
ity of fresh 25 
 
m
 
M SC44463 in DME was compared to that of SC44463 in
48- or 72-h keratinocyte-conditioned medium.
 
Results
 
Collagenase-1 Is Expressed by Migrating Keratinocytes 
In Vivo and In Vitro
 
The epidermis of neonatal human skin grafted onto SCID
mice heals by 4 d after wounding, and reepithelialization is
associated with the expression of identical integrins and
basement membrane proteins produced in actual human
wounds (Juhasz et al., 1993). As demonstrated by in situ
hybridization, collagenase-1 was expressed by human
basal keratinocytes only at the leading edge of reepithe-
lialization (Fig. 1, 
 
B
 
 and 
 
C
 
), identical to the location of en-
 
zyme expression seen in a variety of human wounds and
ulcers (Saarialho-Kere et al., 1992, 1993
 
a
 
, 1995). Collage-
nase-1 mRNA was not expressed in intact skin (Fig. 1 
 
A
 
).
The precise, spatially confined expression of collagenase-1
by migrating keratinocytes suggests that altered cell–matrix
interactions modulate enzyme expression, and indeed, col-
lagenase-1-expressing keratinocytes were seen in intimate
contact with dermal fibrillar collagen (Fig. 1 
 
C
 
).
When grown in DME medium, which contains 1.8 mM
CaCl
 
2
 
, cultured keratinocytes form subpopulations of mi-
grating, proliferating, and differentiating cells (Pentland
and Needleman, 1986). Differentiating keratinocytes are
seen as blurred foci when viewed from above and are sur-
rounded by an apron of hyperproliferative cells (Fig. 2 
 
A
 
).
Bordering the hyperproliferative cells, and often detached
from them, are migrating keratinocytes. Reflecting the phe-
notype of basal cells involved in reepithelialization in vivo,
collagenase-1 mRNA was expressed only in keratinocytes
migrating from the colonies of proliferating and differenti-
ating cells (Fig. 2 
 
A
 
). No signal was seen in cultures hy-
bridized with a 
 
35
 
S-labeled sense RNA probe (data not
shown). With time, proliferating cells and their migrating
daughter cells cover, or “heal,” the tissue culture surface,
and collagenase-1 expression ceases (data not shown).
 
Collagenase-1–expressing Keratinocytes Migrate on 
Type I Collagen
 
To assure that collagenase-1–positive keratinocytes were
migrating, we plated cells on chamber slides coated with a
colloidal gold–type I collagen mixture and fixed the cul-
tures 20 h later. Cells were treated with 30 ng/ml EGF to
augment collagenase-1 production over the relatively short
experimental period. Phagokinetic tracks created were
identified as areas lacking gold particles and were often
seen associated with single cells migrating along the col-
lagen-coated surface (Fig. 2 
 
B
 
). Migration tracks were also
associated with single cells and doublets proximal to kera-
tinocyte foci and were apparently moving away from them
(Fig. 2 
 
C
 
, 
 
arrows
 
). In addition, gold particles were re-
moved at the borders of cell foci (Fig. 2 
 
C
 
), suggesting
zones of collagenolysis. The dark clumps in keratinocytes
seen under phase (Fig. 2 
 
C
 
9
 
) are phagocytized gold parti-
cles. Internalized gold particles were not present in kerati-
nocytes within organized foci (Fig. 2 
 
C
 
9
 
, 
 
large arrows
 
),
where collagenase-1 is not expressed (Fig. 2 
 
A
 
). Thus, the
gold–collagen substrate was removed only in areas that
corresponded to those where high levels of collagenase-1
expression were seen.
To verify that gold particle clearance was dependent on
metalloproteinase activity, we treated keratinocytes with a
peptide hydroxymate inhibitor. This compound is a sub-
strate-based inhibitor containing a hydroxamic acid moi-
ety that chelates the active site zinc cation and renders
MMPs catalytically inactive. SC44463 has a 
 
K
 
i
 
 of about 1 nM
for pure collagenase-1 in solution (Moore and Spilburg,
1986). Treatment with SC44463 completely blocked the
formation of phagokinetic tracks or zones of lysis (Fig. 2,
 
D
 
 and 
 
D
 
9
 
). These observations demonstrate that collage-
nase-1–expressing keratinocytes are migrating and that
this process is inhibited by compounds that block the cata-
lytic activity of this MMP. 
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Figure 1. Collagenase-1 mRNA is expressed by
migrating keratinocytes in contact with dermal
collagen. (A) A section of uninjured neonatal
foreskin grafted onto a SCID mouse was hybrid-
ized with a 35S-labeled antisense RNA probe spe-
cific for collagenase-1 mRNA. No detectable sig-
nal for collagenase-1 mRNA was seen in the
epidermis (E) or the dermis (D) of unwounded
skin. Mouse skin and the graft junctions are not
seen in this field. Under dark-field illumination,
pigmented cells are iridescent and appear pur-
plish. (B) In a section of a biopsy taken 2 d after
wounding grafted human neonatal skin, autora-
diographic signal for collagenase-1 mRNA was
seen in basal keratinocytes at the leading edge of
reepithelialization (arrows). Signal was confined
to keratinocytes migrating into the wound area
(W), under the scab (S), and over the dermal
wound bed (D). No signal was detected in intact
epidermis (E) or in any cell in the dermis. (C) In
a section of pyogenic granuloma, which displays
many features of an acute wound (Saarialho-
Kere et al., 1992), collagenase-1 mRNA was seen
in basal keratinocytes (arrows) along the der-
mal–epidermal junction (arrowheads) at the epi-
dermal front. Collagenase-1–positive basal kera-
tinocytes at the migrating front are in direct
contact with fibrillar collagen (arrowheads),
which appear as thick iridescent fibers under
Nomarski optics. (Inset) Under dark-field illumi-
nation, autoradiographic signal for collagenase-1
mRNA is seen in basal keratinocytes demar-
cated by arrows in the larger photomicrograph.
Autoradiographic exposure was 21 d for all sec-
tions. Bars: (A and B) 100 mm; (C) 25 mm; (Inset)
50 mm. 
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Figure 2. Collagenase-1 mRNA is expressed by migrating keratinocytes in culture. (A) Keratinocytes were plated on dishes precoated with
native type I collagen and 24 h later were processed for in situ hybridization using a 35S-labeled collagenase-1–specific antisense RNA
probe. Signal for collagenase-1 mRNA was seen only in migrating keratinocytes (arrows), whereas no autoradiographic signal was de-
tected in hyperproliferative or differentiating keratinocytes, which appear as blurred foci (f) when viewed from above. Autoradio-
graphic exposure was 14 d. (B–D) Primary human keratinocytes were plated on culture slides coated with a mixture of type I collagen
and colloidal gold particles and were fixed 20 h later. With Nomarski optics (B) or under dark-field illumination (C), tracks of kerati-
nocyte migration were seen as areas devoid of gold particles (arrows). (B) Often, single cells were seen migrating along large bundles of
collagen fibers. (C) Gold was also removed along the border of keratinocyte foci and in association with cells (arrows) that had appar-
ently migrated from the keratinocyte islands. Under phase (C9), internalized gold particles were seen as dense accumulations in kerati-
nocytes. No internalized gold was evident in cells within foci (large arrows). (D and D9) No migration tracks or areas of lysis around cell
foci were seen in cultures treated with SC44463. Bars: (A) 50 mm; (B) 12 mm; (C–D9) 25 mm.The Journal of Cell Biology, Volume 137, 1997 1450
Collagenase-1–deficient HaCaT Keratinocytes Migrate 
on Gelatin but Not on Native Type I Collagen
To begin to assess if keratinocyte migration specifically re-
quires the activity of collagenase-1, we assessed the ability
of HaCaT cells, which do not express collagenase-1 in re-
sponse to native type I collagen (see Fig. 4 A), to migrate
on native or denatured collagen. HaCaT cells were plated
within cloning cylinders on dishes coated with type I col-
lagen or gelatin (heat-denatured type I collagen). The cyl-
inders were removed 24 h later, and the cells were allowed
to migrate for 48 h. HaCaT cells cultured on native type I
collagen did not migrate from the colony border, whereas
cells grown on gelatin-coated dishes migrated efficiently
from the cell colony (Fig. 3). MMP inhibitors did not affect
HaCaT migration on gelatin (data not shown). Because
the primary cleavage products of collagenase-1 denature
at 378C but are not further degraded, we hypothesized that
collagenase-1–mediated cleavage of collagen followed by
denaturation to gelatin is required for effective migration.
Induction of Collagenase-1 Expression by HaCaT 
Keratinocytes Induces Migration on Type I Collagen
High levels of collagenase-1 production were induced in
HaCaT keratinocytes after exposure to 30 ng/ml EGF (Fig.
4 A). As we saw in the primary keratinocyte cultures (Fig.
2 A), HaCaT cells formed tightly packed colonies, and col-
lagenase-1 mRNA was expressed only by cells at the pe-
riphery of the foci (Fig. 4 B). In contrast, HaCaT cells
within the cell colony had no detectable collagenase-1
mRNA. Although EGF potently induced collagenase-1
expression, enzyme production was confined only to mi-
grating cells, or at least to cells with the potential to mi-
grate.
Supporting the idea that collagenase-1 is required for
keratinocyte motility on dermal matrix, EGF-treated cells
migrated progressively on a type I collagen–coated surface
over a 4-d period (Fig. 4 D). At 96 h, EGF-stimulated cells
covered an area four times greater than that of untreated
HaCaT cells, which did not produce collagenase-1 (Fig. 4 A)
and which had not progressed far from the border of the
cloning cylinder (Fig. 4, C and D). The small increase in
colony area evident at 72 and 96 h in control HaCaT cells
was likely due to cell proliferation.
HaCaT Migration on Type I Collagen Requires
MMP Activity 
Induction of HaCaT cell migration on type I collagen by
EGF suggests that the activity of collagenase-1 facilitates
cell movement on this matrix. Indeed, treatment of HaCaT
cells with SC44463 inhibited EGF-mediated cell migration
z50% in the colony dispersion assay (Fig. 4 E, 2HU). The
incomplete inhibition of cell migration in SC44463-treated
cultures was likely due to EGF-stimulated cell prolifera-
tion, thereby increasing colony size independent of cell
Figure 3. Collagenase-1–negative HaCaT keratinocytes migrate
on gelatin but not on native type I collagen. HaCaT cells were
grown within cloning cylinders on dishes precoated with type I
collagen (Col) or gelatin (Gel). The cylinders were removed 24 h
later, and cells were allowed to migrate for 48 h. The arrows des-
ignate the border of the culture when the cloning cylinder was re-
moved. The micrographs shown are representative of three ex-
periments.Pilcher et al. Collagenase-dependent Migration 1451
movement per se. To neutralize the proliferative effects of
EGF, cell colonies were pretreated for 24 h with HU, an
effective inhibitor of DNA synthesis and cell division. The
antiproliferative effect of HU pretreatment was dose de-
pendent and persisted up to 96 h as determined by [3H]thy-
midine incorporation (data not shown). Under these con-
ditions, EGF-stimulated cells migrated on collagen, but
they did not cover an area as large as EGF-treated HaCaT
cells not preexposed to HU (Fig. 4 E, 1HU). Addition of
SC44463 completely blocked EGF-mediated cell migration
Figure 4. HaCaT migration
on native type I collagen is
MMP dependent. (A)
HaCaT keratinocytes were
grown on type I collagen–
coated dishes and treated
with or without 30 ng/ml
EGF. Collagenase-1 accumu-
lation in the medium was as-
sessed 48 h later by ELISA
and normalized to total cellu-
lar protein. (B) HaCaT cells
were plated on collagen-
coated slides, stimulated with
EGF, and 24 h later were
processed for in situ hybrid-
ization with a collagenase-1
35S-labeled antisense RNA
probe. Only HaCaT cells at
the periphery of cell clusters
expressed collagenase-1
mRNA. Autoradiographic
exposure was 14 d. (C–E)
HaCaT cells were plated
within cloning cylinders on
collagen-coated dishes. Af-
ter 24 h, the cylinders were
removed, and the cells were
allowed to migrate on col-
lagen alone or in the pres-
ence of EGF for 48, 72, or
96 h. Cells were stained, and
the area migrated was quan-
tified by scanning densitome-
try. (E) During the initial
24-h culture period, some
HaCaTs were treated with
100 mM HU to inhibit EGF-
mediated proliferation. The
cylinders were removed, and
the cells were given fresh me-
dium with or without 30 ng/
ml EGF or EGF plus 25 mM
peptide hydroxymate inhibi-
tor SC44463. After 96 h, cul-
tures were washed and
stained, and migration was
quantified by image analysis.
Migration data for HaCaT
cells pretreated with (1HU)
or without (2HU) HU are
shown. The data in D and E
are the means 6 SD or tripli-
cate wells and are expressed
in arbitrary units relative to
0-h controls. (F) HaCaT ke-
ratinocytes were plated on culture slides coated with a mixture of colloidal gold particles and type I collagen (Col) or gelatin (Gel).
Cells on collagen-coated chambers were treated with 30 ng/ml EGF. To inhibit collagenase-1 activity, cells were treated with (1) or
without (2) collagenase-1 affinity-purified antibody or 25 mM SC44463 and were fixed 20 h later. Keratinocyte migration was quanti-
fied as described under Materials and Methods, and the data shown are the means 6 SEM of duplicate samples from four experiments.The Journal of Cell Biology, Volume 137, 1997 1452
on type I collagen (Fig. 4 E, 1HU). These results demon-
strate that EGF-mediated HaCaT migration on type I col-
lagen is an MMP-dependent process.
Because the colony dispersion assay requires treatment
with EGF for 96 h to see appreciable migration, we cannot
conclude that cell movement is due specifically and solely
to collagenase-1 activity. To address this concern, we used
the colloidal gold assay to assess keratinocyte migration
over a relatively shorter period of time (20 h). Duplicating
the findings of the colony dispersion assay, EGF-treated
HaCaTs migrated efficiently as single cells on a colloidal
gold–collagen substratum, and this activity was blocked by
SC44463 (Fig. 4 F). Migration was also completely inhib-
ited by treatment with affinity-purified anti–collagenase-1
antibody, which blocks the catalytic activity of this MMP.
Untreated HaCaT keratinocytes migrated efficiently on
gelatin, and cell movement on this substrate was not af-
fected by the blocking antibody (Fig. 4 F). These findings
indicate that EGF-mediated migration of HaCaT kerati-
nocytes on native collagen requires the activity of collage-
nase-1.
Migration of Primary Human Keratinocytes
In contrast to HaCaT cells, collagenase-1 is induced in pri-
mary human keratinocytes grown on native type I collagen
(Sudbeck et al., 1994). 120 h after plating, primary kerati-
nocytes cultured on collagen alone migrated well beyond
the original cell colony border (Fig. 5), and addition of the
MMP inhibitor SC44463 completely blocked this response
(Fig. 5). The ability of SC44463 to inhibit cell migration was
dose dependent over a range of 0.1 to 25 mM, demonstrat-
ing an z50% reduction in cell movement with 1.0 mM in
both EGF-stimulated HaCaT keratinocyte and primary hu-
man keratinocyte cultures (data not shown). Compound
SC44201, a stereoisomer of 44463 differing only in the
plane of a single hydrogen atom, is a weak inhibitor of
MMP activity, with a relative Ki for all MMPs over 1,000-
fold greater than that of SC44463 (Moore and Spilburg,
1986). Consistent with the idea that keratinocyte migration
on type I collagen is MMP dependent, SC44201 did not af-
fect cell movement (Fig. 5). As determined by a [3H]leu-
cine pulse and trichloroacetic acid precipitation, the hy-
droxymate compounds at concentrations up to 25 mM did
not affect the synthesis of total secreted protein (Table I).
Furthermore, as determined by an in vitro MMP activity
assay, the inhibitory activity of SC44463 was not dimin-
ished after 72 h in culture (Table II).
Primary Keratinocytes Do Not Migrate on
Collagenase-resistant Type I Collagen
Inhibition of keratinocyte migration on type I collagen by
the peptide hydroxymate compound demonstrated that
MMP activity was required for cell motility. This com-
pound, like other hydroxymates, inhibits a broad spectrum
of metalloproteinases (Moore and Spilburg, 1986). There-
fore, based on these data alone, we cannot conclude that
collagenase-1 is the specific MMP required for migration
on collagen. Because primary keratinocytes have the po-
tential to express other MMPs, namely 92-kD gelatinase
(Sudbeck et al., 1997), stromelysin-1, and stromelysin-2
(Windsor et al., 1993; Saarialho-Kere et al., 1994), we used
more specific reagents to determine which enzyme is re-
quired for migration. Northern hybridization demonstrated
that human keratinocytes express only collagenase-1 and
do not produce collagenase-2 or -3 (data not shown).
To determine if the proteolytic activity of collagenase-1
is required for cell motility, we cultured primary human
keratinocytes on a collagenase-resistant mutant type I col-
lagen. Human collagenase-1 cleaves fibrillar type I collagen
at Gly775-Ile776 in the a1(I) chains and at Gly775-Leu776 in
the a2(I) chain, and these sites are conserved among mam-
malian type I collagens. This cleavage renders the mole-
cule thermally unstable and susceptible to further degra-
dation by other proteinases. The mutant collagen used in
this study contains a double substitution of Pro for Glu774
and Ala777 and Met for Ile776 in the region of the collage-
nase cleavage site of the a1(I) chain, rendering the mole-
cule resistant to proteolysis by collagenase-1 (Wu et al.,
1990; Liu et al., 1995). Collagenase-1 expression was in-
duced in primary keratinocytes grown on wild-type native
Figure 5. Keratinocyte migration on native type I collagen is MMP
dependent. Primary human keratinocyte migration was assessed
by the colony dispersion assay. Cells were cultured on collagen
with or without peptide hydroxymate compounds SC44463 or
SC44201. The data shown are the means 6 SD of triplicate wells
and are expressed in arbitrary units relative to 0-h controls.
Table I. Protein Synthesis
Treatment Protein synthesis
cpm/106 cells
Collagen alone 2836 6 551
1 SC44463 2783 6 816
1 SC44201 3627 6 353
Keratinocytes were plated on type I collagen and treated with 25 mM of the indicated
peptide hydroxymate compound for 24 h. Cultures were then incubated for 1 h in leu-
cine-free medium to deplete intracellular pools and then pulsed for 24 h in leucine-free
medium containing 1 mCi/ml L-[3H]leucine in the presence or absence of hydroxy-
mate compounds. Radioactivity incorporated into acid precipitable material in the
conditioned medium was determined 24 h later. The data presented are the means 6
standard deviations of triplicate determinations from three separate plates per treat-
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type I collagen, and cells migrated efficiently across this
matrix (Fig. 6, A and B). In contrast, keratinocytes cul-
tured on collagenase-resistant mutant collagen did not mi-
grate, although enzyme expression was induced (Fig. 6, A
and B). As an internal control, inhibition of all MMP ac-
tivity with SC44463 completely inhibited the ability of
these cells to migrate on native type I collagen (Fig. 6 A).
Keratinocytes plated on mutant type I collagen adhered
equally to those on wild-type collagen and expressed colla-
genase-1, indicating that the cell-recognition site is distinct
from the enzyme cleavage site.
Migration of Primary Keratinocytes on Type I Collagen 
Is Blocked by Collagenase Antibodies
In both the colony dispersion and colloidal gold assays,
anti–collagenase-1 antibodies inhibited keratinocyte mi-
gration in a dose-dependent fashion, whereas cell motility
was not affected by nonimmune IgG (Fig. 7, A and B). The
concentrations of collagenase-1 antibody that inhibited
cell migration are the same as those that blocked activity
of pure enzyme in solution (data not shown). In addition,
human recombinant TIMP-1, a naturally occurring inhibi-
tor of collagenase-1 and other MMPs, inhibited cell migra-
tion (Fig. 7 A).
In the colloidal gold assay, most keratinocytes showed
evidence of migration on collagen (Fig. 7 C). Collagenase-1
antibody blocked keratinocyte migration on native type I
collagen proportionately to the concentration of antibody
added (Fig. 7 B). Similar to the inhibition seen with
SC44463 (Fig. 7 B), essentially no migration was seen in
cultures treated with the highest concentration of antibody
(Fig. 7, B and D). In contrast, collagenase-1 antibody did
not affect keratinocyte migration on gelatin (Fig. 7, B and
E). Keratinocyte migration on gelatin was slightly reduced
compared to that on collagen, likely because the cells did
not adhere as efficiently to the heat-denatured substrate.
These findings demonstrate that the proteolytic activity of
collagenase-1, and not that of other MMPs, is required for
keratinocyte migration on native type I collagen.
Integrin-mediated Induction of Collagenase-1
To assess which integrin–matrix interactions transduce the
collagen-mediated induction of collagenase-1, we treated
primary keratinocytes plated on native collagen with a1-,
a2-, or a3-blocking antibodies. Each of these subunits is
expressed by basal keratinocytes in intact and wounded
skin and complex with the b1 subunit to form potential
collagen-binding receptors (Larjava et al., 1993; Lange et al.,
1994). Collagen-mediated induction of collagenase-1 mRNA
was potently inhibited by treatment with the a2 antibody
but not by antibodies against the a1 or a3 subunits (Fig.
8). Blocking collagenase-1 expression with the a2b1 anti-
body inhibited keratinocyte migration on collagen by z75%
relative to untreated controls, whereas cell movement was
unaffected by the a1 or a3 antibodies (Fig. 8). To prevent
potential disruption of cell attachment to collagen, we
added the integrin-blocking antibodies 2 h after kerati-
nocytes were plated, and migration and collagenase-1
mRNA levels were assessed 20 h later. Although collage-
nase-1 mRNA levels were completely repressed by 20 h,
some migration was evident, which may be because of
Table II. Sustained Inhibitory Activity of SC44463
Treatment
Percent inhibition of 92-kD gelatinase
catalytic domain (CD) activity
92-kD CD Alone 0
92-kD CD 1 0 h CM 99.73
92-kD CD 1 48 h CM 99.59
92-kD CD 1 72 h CM 99.41
Keratinocytes were plated on type I collagen in medium containing 25 mM SC44463
for 0, 48, or 72 h. The inhibitory activity of SC44463 in conditioned medium (CM)
was compared to that of fresh (0 h) SC44463 by assessing the ability of 92-kD gelati-
nase catalytic domain to hydrolyze a thiopeptolide substrate.
Figure 6. Keratinocytes do
not migrate on a collagenase-
resistant type I collagen. (A)
Primary human keratinocyte
migration on native type I
collagen or on collagenase-
resistant type I collagen was
assessed by the colony dis-
persion assay. After 24 h, the
cylinders were removed, and
the cells were allowed to mi-
grate for 120 h. Some cultures
on native type I collagen
were exposed to 25 mM
SC44463 during the 120-h
migration period. The data
are the means 6 SD of tripli-
cate wells, and migration is
expressed in arbitrary units
relative to 0-h controls. (B)
Keratinocytes were grown to
confluence on gelatin, type I collagen, or mutant type I collagen. Collagenase-1 accumulation in conditioned medium at 72 h was deter-
mined by ELISA and normalized to total protein. Gelatin was included as a substrate that does not stimulate collagenase-1 expression
in keratinocytes.The Journal of Cell Biology, Volume 137, 1997 1454
some collagenase-1 produced during the 2-h attachment
period.
Discussion
In this report, we demonstrate that the production and
activity of collagenase-1 is required for keratinocyte mi-
gration on native type I collagen. In response to cutaneous
injury, basal keratinocytes at the edge of the wound dis-
lodge, dissolve, or loosen their cell–cell and cell–matrix
contacts, move from the basement membrane, and mi-
grate in an organized front over the viable dermis and
wound bed. Initiation of keratinocyte migration is one of
the earliest responses of the epidermis to wounding and
precedes by hours stimulation of cell proliferation (Garlick
and Taichman, 1994). As we have shown in several differ-
ent types of human wounds (Saarialho-Kere et al., 1992,
1993a, 1995), collagenase-1 is invariably expressed by
Figure 7. Keratinocyte migration on type I collagen is collagenase-1-dependent. (A) Colony dispersion. Primary human keratinocytes
were grown for 24 h within cloning cylinders on type I collagen. The cloning cylinders were removed, and cells were allowed to migrate
for 120 h on collagen in the presence of affinity-purified collagenase-1 antibody (C9ase-1 Ab) at the indicated dilutions or nonimmune
IgG or 50 mg/ml recombinant human TIMP-1. The data presented are means 6 SD of values from three separate wells per treatment
group, and migration is expressed in arbitrary units relative to 0-h controls. (B) Colloidal gold. Primary human keratinocytes were
plated on culture slides coated with colloidal gold particles and type I collagen or gelatin and the indicated titers of affinity-purified col-
lagenase-1 antibody or 25 mM SC44463 and were fixed 20 h later. Keratinocyte migration was quantified as described under Materials
and Methods, and the data shown are the means 6 SEM of duplicate samples from four experiments. The lower panels are dark-field il-
luminated micrographs of keratinocytes on collagen alone (C), on collagen plus collagenase-1 antibody at 1:2 dilution (D), or on gelatin
plus collagenase-1 antibody at 1:2 dilution (E).Pilcher et al. Collagenase-dependent Migration 1455
keratinocytes that have moved off of the basement mem-
brane and onto the underlying matrix, and studies by Inoue
et al. (1995) demonstrated that collagenase-1 is induced as
soon as 4 h after wounding. The confinement of collage-
nase-1 expression to a spatially defined subpopulation of
keratinocytes suggests that altered cell–matrix contacts
mediate induction of this MMP. Indeed, as we demon-
strate here, contact with dermal type I collagen induces
collagenase-1 expression only by migrating keratinocytes
(Fig. 2 A). Other components of the dermal and provi-
sional matrices, such as type III collagen, fibronectin, and
fibrin, do not induce or affect collagenase-1 production or
are not even recognized by keratinocytes (Sudbeck, B.D.,
B.K. Pilcher, H.G. Welgus, and W.C. Parks, unpublished
observations). Consistent with the idea that migration
from basement membrane onto a type I collagen–contain-
ing matrix is required for collagenase-1 expression, this
MMP is not induced in keratinocytes grown on basement
membrane proteins (Saarialho-Kere et al., 1993a; Sudbeck
et al., 1994). Thus, altered cell–matrix interactions, and in
particular, contact with dermal type I collagen, may ini-
tiate the keratinocyte’s response to injury, which is charac-
terized by the expression of collagenase-1 at the migrating
front.
We propose that collagenase-1 acting on its principal
substrate in the dermis, type I collagen, provides migrating
keratinocytes with a mechanism to maintain their course
and directionality in the wound environment during reepi-
thelialization. In intact skin, basal keratinocytes constitu-
tively express the type I collagen–binding integrin a2b1
along their basolateral surfaces (Hertle et al., 1991; Sym-
ington et al., 1993). In wounded epidermis, migrating kera-
tinocytes continue to express their collagen-binding recep-
tors (Cavani et al., 1993; Hertle et al., 1992; Juhasz et al.,
1993), but a2b1 becomes redistributed and concentrated
at the frontobasal end of the cells (Guo et al., 1991). This
redistribution places a2b1 where it would likely come into
intimate contact with dermal type I collagen. Although
basal keratinocytes also express a1b1 and a3b1, kerati-
nocytes preferentially use a2b1 to bind to type I collagen
(Lange et al., 1994). Indeed, we demonstrate that blocking
the ability of this integrin to bind type I collagen inhibits
collagenase-1 expression and, consequently, keratinocyte
migration, whereas blocking ligand interaction to a1b1 or
a3b1 did not affect enzyme production or cell movement
(Fig. 8). In contrast, Zhang and Kramer (1996) reported
that blocking antibodies to a3b1 inhibited keratinocyte
migration on collagen. However, in their assays, inhibition
of cell movement was seen at a concentration of collagen
at which we have demonstrated to be a weak stimulator of
collagenase-1 expression (Saarialho-Kere et al., 1993a). At
higher concentrations of collagen, cell migration was barely
inhibited (Zhang and Kramer, 1996). Still, their data sug-
gest that a3b1 plays a role in keratinocyte migration, but
our findings indicate that this integrin does not influence
collagenase-1 expression or collagenase-1–dependent mo-
tility.
a2b1 binds native collagen with high affinity (Staatz et al.,
1989), and thus, clustering of this integrin at the forward
edge of keratinocytes may actually tether the cells to the
matrix, rendering them unable to migrate. Therefore, the
proteolytic activity of collagenase-1 may aid in dissociating
keratinocytes from these high-affinity attachments to a
collagen matrix. As stated, collagenase-1 does not degrade
fibrillar type I collagen but rather makes a single, site-spe-
cific cleavage through the triple helix about 3/4 the length
from the NH2 terminus. The resultant fragments, called
TCA and TCB fragments, are thermally unstable at body
temperature and may spontaneously denature into gelatin.
Besides being highly susceptible to complete degradation
by different proteinases, gelatin binds a2b1 with a much
lower affinity than does native collagen (Staatz et al., 1989).
Thus, we speculate that by cleaving type I collagen, which
then denatures into gelatin, collagenase-1 effectively me-
diates the loosening of the tight contacts keratinocytes
may establish with the dermal matrix. This function is dis-
tinct from the often suggested idea that migrating cells use
metalloproteinases to remove matrix barriers that may
physically impede movement.
Although keratinocytes may actually migrate on other
molecules found in the provisional wound matrix, such as
fibronectin and vitronectin, the proteolytic activity of col-
lagenase-1 is still needed to initiate and maintain this pro-
cess. Basal HaCaT cells did not express collagenase-1 (Fig.
4  A) and did not migrate on a collagen matrix, even
though serum adhesive proteins were present (Figs. 3 and
4). These cells did, however, migrate easily on a gelatin
matrix (Fig. 3), and stimulation of collagenase-1 expression
by exogenous EGF induced migration of HaCaT cells on
type I collagen (Fig. 4). Furthermore, we were able to
block migration of primary human keratinocytes by any
method that perturbed the ability of collagenase-1 to
cleave collagen, be it addition of hydroxymate inhibitors,
Figure 8. Collagen-mediated induction of collagenase-1 is a2 in-
tegrin dependent. Primary human keratinocytes were plated on
collagen-coated slides with or without colloidal gold particles,
and 2 h later, blocking antibodies (10 mg/ml) against the indicated
integrin subunits were added. 20 h after plating, migration was as-
sessed on gold-coated slides, and cells on slides without gold were
harvested for RNA isolation. Collagenase-1 mRNA was assessed
by reverse transcriptase–PCR, and densitometry was used to
quantify relative signal strength. For both assays, migration area
and collagenase-1 mRNA levels were normalized to the levels
detected in cells on collagen alone.The Journal of Cell Biology, Volume 137, 1997 1456
collagenase-1–blocking antibodies, or TIMP-1 or plating
cells on collagenase-resistant collagen (Figs. 5, 6 and 7). In
addition, blocking the induction of collagenase-1 expres-
sion in primary keratinocytes by treatment with a2 anti-
body inhibited keratinocyte migration. We do not inter-
pret these data to indicate that a2b1 binding to collagen is
directly required for keratinocyte migration, but rather
that this cell–matrix interaction mediates induction of col-
lagenase-1, which, in turn, is essential for cell movement.
As stated, we propose that collagenase-1 facilitates ke-
ratinocyte migration by affecting the conformation of type
I collagen and, consequently, the avidity with which cells
interact with it. One may argue that this is an inherently
inefficient mechanism. If activated keratinocytes migrate
over the viable dermis interacting with provisional matrix
proteins, then why do they need to cleave type I collagen?
Why would they adhere to the dermis with high affinity if
their objective is to close the wound as quickly as possible?
The answer, we believe, is that the process of interacting
with and then cleaving type I collagen provides kerati-
nocytes with a mechanism to determine and maintain their
directionality during reepithelialization.
An important observation relevant to our directionality
hypothesis is that collagenase-1 production is induced in
keratinocytes by native type I collagen but not by dena-
tured forms of the molecule (see Fig. 6 B and Sudbeck et
al., 1994). Thus, collagenase-1 acting on collagen creates a
mediator that does not support or maintain its own pro-
duction. The conversion of collagen to gelatin would re-
place the inductive stimulus with a neutral substrate (gela-
tin), and in stationary cells, collagenase-1 expression would
decline. Indeed, collagenase-1 expression is rapidly turned
off at the completion of reepithelialization (Inoue et al.,
1995). Although cell–cell contacts may be involved in this
process, the initial expression of collagenase-1 may medi-
ate cleavage of the collagen substrate, thereby neutralizing
the inductive effect of the underlying matrix. If keratinocytes
continue to interact with type I collagen, presumably by mi-
grating, then they would continue to express collagenase-1.
During wound healing in vivo, collagenase-1 cleavage of
collagen would leave a trail of denatured collagen (gela-
tin) that would not attract keratinocyte attachment. Using
high-affinity interactions with native type I collagen as a
“molecular compass,” keratinocytes could then bind to
components of the provisional matrix to support motility.
Because gelatin does not induce or maintain collagenase-1
expression, keratinocytes would not have the proteinase
needed to invade into the dermis if they would begin to
stray. The activity of collagenase-1 would allow keratino-
cytes to break away from collagen while it continually ex-
tends and interacts with new native collagen molecules
present in the superficial plane of the viable dermis. In a
stratified epithelium, cell migration is thought to proceed
in a leap-frog fashion, whereby the cell at the front extends
along and attaches to the matrix and is replaced by cells
coming from behind and above (see Stenn and Malhotra,
1992). Thus, these interrelated collagenolytic and migra-
tory processes may occur within a limited microenviron-
ment.
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